Roche Diagnostics India launches the country’s first-of-its-kind automated solution for IVD labs

cobas® pro reaches India within months of its initial launch in European markets

• Industry’s largest test menu in a single system
• cobas pro integrated solution allows for up to 2,200 tests per hour
• Continuous reagent loading, Automated maintenance, Automated calibration
• Shortened time in delivering test results to physicians, clinicians and patients

Mumbai, July 10, 2019: Roche Diagnostics India today announced the launch of its latest diagnostic technology – cobas® pro integrated solutions – which brings to India’s IVD labs an opportunity to establish several ‘first-of-its-kind’ features. This solution includes time-saving and efficiency-building features like automated maintenance and calibration and an on-the-fly reagent loading mechanism.

Dr Shravan Subramanyam, Managing Director – Roche Diagnostics India, said, “Innovation to suit evolving lab and patient needs are at the heart of everything we do in Roche. I am excited about today’s launch of cobas pro in India because it addresses almost all of the challenges of today’s labs – reduced turnaround time, maintaining testing efficiency in limited space settings, less fatigue and improved productivity of lab personnel on account of automation and a single window into the industry’s largest test portfolio.

With cobas pro integrated solutions, Roche Diagnostics India is equipped to partner with labs across the country to meet with their needs of tomorrow. That it can seamlessly integrate into Roche and other lab automation systems makes it attractive to lab management. It gives IVD labs an opportunity to experience the merits of digitalisation and automation, with the added benefit of Roche’s support in upskilling their technicians.

I am excited that some of the sustainability matrices of cobas pro integrated solutions are most relevant to India’s needs. For instance, with cobas pro a lab uses one-third the amount of water required for a test in comparison to other analysers.”

Dr. Benjamin Lilienfeld, International Business Leader, SWA Systems, Roche Diagnostics International said, “The cobas pro integrated solutions is Roche Diagnostics’ response to the needs of diagnostic labs and patients. The result is a revolutionary solution that offers greater automation, flexibility and a simplified workflow to support better clinical outcomes for patients.

cobas pro represents Roche’s new generation of Serum Work Area solutions that endeavours to improve the speed and reliability of treatment decisions for patients and their families. They are designed to reduce the time between diagnosis and therapy management, and to instill greater confidence in clinical decision making.

In tangible terms, cobas pro reduces daily maintenance time to 8 mins only, whilst it has a proven reduction of up to 90 hours’ hands-on time for calibration every year (as compared to cobas 6000), significantly improving productivity of lab professionals. The ready-to-use reagents requiring no preparation time is another advantage for lab technicians to allocate their instrument and services time efficiently.

We are delighted that our instruments are able to bring healthcare innovation to India.”

cobas pro is available for diagnostic labs across India.

Corporate Comm India(CCI Newswire)